Abstract
Micro- or minimally invasive glaucoma surgery (MIGS) refers to a group of relatively newer devices and procedures aimed at lowering eye pressure through less invasive surgical approaches compared to traditional filtering procedures. In a joint meeting, the United States Food and Drug Administration (FDA) and the American Glaucoma Society defined MIGS as surgical procedures and devices that decrease intraocular pressure while requiring less tissue dissection than traditional glaucoma filtering surgery [1]. Since the early 2000s, a variety of MIGS devices have been approved for use, including Schlemm’s canal devices and procedures, subconjunctival devices, suprachoroidal devices, and cycloablation devices. According to Centers for Medicare Services (CMS) data collected from all glaucoma surgeries performed for Medicare beneficiaries, there was a 426% increase in MIGS procedures from 2012 to 2016 [2]. American Academy of Ophthalmology Intelligent Research in Sight (IRIS®) Registry data showed that among eyes with a documented diagnosis of glaucoma, there was a substantial increase in annual MIGS procedures from 2013 to 2018 (7586 to 39,677) and a decrease in traditional glaucoma surgeries (from 16,215 to 13,701), reflecting the increased popularity of MIGS as less invasive surgical options for treating glaucoma [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Caprioli J, Kim JH, Friedman DS, et al. Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC, February 26, 2014. Ophthalmology. 2015;122(9):1795–801. https://doi.org/10.1016/j.ophtha.2015.02.029.
Rathi S, Andrews CA, Greenfield DS, Stein JD. Trends in glaucoma surgeries performed by glaucoma subspecialists versus nonsubspecialists on Medicare beneficiaries from 2008 through 2016. Ophthalmology. 2021;128(1):30–8. https://doi.org/10.1016/j.ophtha.2020.06.051.
Yang SA, Mitchell W, Hall N, et al. Trends and usage patterns of minimally invasive glaucoma surgery in the united states: iris® registry analysis 2013–2018. Ophthalmol Glaucoma. 2021;4(6):558–68. https://doi.org/10.1016/j.ogla.2021.03.012.
Minckler DS, Baerveldt G, Alfaro MR, Francis BA. Clinical results with the Trabectome for treatment of open-angle glaucoma. Ophthalmology. 2005;112(6):962–7. https://doi.org/10.1016/j.ophtha.2004.12.043.
Wang Y, Liang ZQ, Zhang Y, Hennein L, Han Y, Wu HJ. Efficacy and safety of phacoemulsification plus goniosynechialysis and trabectome in patients with primary angle-closure glaucoma. Sci Rep. 2021;11(1):13921:13921. https://doi.org/10.1038/s41598-021-92972-9.
Pahlitzsch M, Gonnermann J, Maier AB, Bertelmann E, Klamann MK, Erb C. Modified goniotomy as an alternative to trabectome in primary open angle glaucoma and pseudoexfoliation glaucoma: 1 year results. Can J Ophthalmol. 2017;52(1):92–8. https://doi.org/10.1016/j.jcjo.2016.07.011.
Wecker T, Neuburger M, Bryniok L, et al. Ab Interno trabeculectomy with the Trabectome as a valuable therapeutic option for failed filtering blebs. J Glaucoma. 2016;25(9):758–62. https://doi.org/10.1097/ijg.0000000000000492.
Ngai P, Kim G, Chak G, Lin K, Maeda M, Mosaed S. Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma. Medicine (Baltimore). 2016;95(50):e5383. https://doi.org/10.1097/md.0000000000005383.
Swamy R, Francis BA, Akil H, Yelenskiy A, Chopra V, Huang A. Clinical results of ab interno trabeculotomy using the trabectome in patients with uveitic glaucoma. Clin Exp Ophthalmol. 2020;48(1):31–6. https://doi.org/10.1111/ceo.13639.
Den Beste KA, Okeke C. Trabeculotomy ab interno with Trabectome as surgical management for systemic fluoroquinolone-induced pigmentary glaucoma: a case report. Medicine (Baltimore). 2017;96(43):e7936. https://doi.org/10.1097/md.0000000000007936.
Bussel II, Kaplowitz K, Schuman JS, Loewen NA. Outcomes of ab interno trabeculectomy with the trabectome after failed trabeculectomy. Br J Ophthalmol. 2015;99(2):258–62. https://doi.org/10.1136/bjophthalmol-2013-304717.
Mosaed S, Chak G, Haider A, Lin KY, Minckler DS. Results of Trabectome surgery following failed glaucoma tube shunt implantation: cohort study. Medicine (Baltimore). 2015;94(30):e1045. https://doi.org/10.1097/md.0000000000001045.
Bendel RE, Patterson MT. Long-term effectiveness of Trabectome (ab-interno trabeculectomy) surgery. J Curr Glaucoma Pract. 2018;12(3):119–24. https://doi.org/10.5005/jp-journals-10028-1256.
Kono Y, Kasahara M, Hirasawa K, et al. Long-term clinical results of trabectome surgery in patients with open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2020;258(11):2467–76. https://doi.org/10.1007/s00417-020-04897-0.
Jordan JF, Wecker T, van Oterendorp C, et al. Trabectome surgery for primary and secondary open angle glaucomas. Graefes Arch Clin Exp Ophthalmol. 2013;251(12):2753–60. https://doi.org/10.1007/s00417-013-2500-7.
Tojo N, Abe S, Hayashi A. Factors that influence of Trabectome surgery for glaucoma patients. J Glaucoma. 2017;26(9):835–44. https://doi.org/10.1097/ijg.0000000000000743.
Jea SY, Mosaed S, Vold SD, Rhee DJ. Effect of a failed trabectome on subsequent trabeculectomy. J Glaucoma. 2012;21(2):71–5. https://doi.org/10.1097/IJG.0b013e31820bcfda.
Ahuja Y, Malihi M, Sit AJ. Delayed-onset symptomatic hyphema after ab interno trabeculotomy surgery. Am J Ophthalmol. 2012;154(3):476–480.e2. https://doi.org/10.1016/j.ajo.2012.03.027.
Minckler D, Mosaed S, Dustin L, Ms BF. Trabectome (trabeculectomy-internal approach): additional experience and extended follow-up. Trans Am Ophthalmol Soc. 2008;106:149–59. discussion 159–60
Mizoguchi T, Nishigaki S, Sato T, Wakiyama H, Ogino N. Clinical results of Trabectome surgery for open-angle glaucoma. Clin Ophthalmol. 2015;9:1889–94. https://doi.org/10.2147/opth.s83958.
Wang Q, Harasymowycz P. Goniopuncture in the treatment of short-term post-Trabectome intraocular pressure elevation: a retrospective case series study. J Glaucoma. 2013;22(8):e17–20. https://doi.org/10.1097/IJG.0b013e3182595042.
Minckler D, Baerveldt G, Ramirez MA, et al. Clinical results with the Trabectome, a novel surgical device for treatment of open-angle glaucoma. Trans Am Ophthalmol Soc. 2006;104:40–50.
Ting JLM, Rudnisky CJ, Damji KF. Prospective randomized controlled trial of phaco-trabectome versus phaco-trabeculectomy in patients with open angle glaucoma. Can J Ophthalmol. 2018;53(6):588–94. https://doi.org/10.1016/j.jcjo.2018.01.033.
Craven ER, Katz LJ, Wells JM, Giamporcaro JE. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38(8):1339–45. https://doi.org/10.1016/j.jcrs.2012.03.025.
Belovay GW, Naqi A, Chan BJ, Rateb M, Ahmed IIK. Using multiple trabecular micro-bypass stents in cataract patients to treat open-angle glaucoma. J Cataract Refract Surg. 2012;38(11):1911.
Katz LJ, Erb C, Carceller GA, et al. Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication. Clin Ophthalmol. 2015;9:2313–20. https://doi.org/10.2147/opth.s96695.
Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118(3):459–67. https://doi.org/10.1016/j.ophtha.2010.07.007.
iStent inject W. Glaukos. Accessed 04 Nov 2021. https://www.glaukos.com/healthcare-professionals/istent-inject-w/
Ahmed II, Katz LJ, Chang DF, et al. Prospective evaluation of microinvasive glaucoma surgery with trabecular microbypass stents and prostaglandin in open-angle glaucoma. J Cataract Refract Surg. 2014;40(8):1295–300. https://doi.org/10.1016/j.jcrs.2014.07.004.
Ferguson TJ, Ibach M, Schweitzer J, Karpuk KL, Stephens JD, Berdahl JP. Trabecular micro-bypass stent implantation with cataract extraction in pigmentary glaucoma. Clin Exp Ophthalmol. 2020;48(1):37–43. https://doi.org/10.1111/ceo.13638.
Buchacra O, Duch S, Milla E, Stirbu O. One-year analysis of the iStent trabecular microbypass in secondary glaucoma. Clin Ophthalmol. 2011;5:321–6.
Morales-Fernandez L, Martinez-De-La-Casa JM, Garcia-Feijoo J, Diaz Valle D, Arriola-Villalobos P, Garcia-Sanchez J. Glaukos(®) trabecular stent used to treat steroid-induced glaucoma. Eur J Ophthalmol. 2012;22(4):670–3. https://doi.org/10.5301/ejo.5000073.
Guedes RAP, Gravina DM, Lake JC, Guedes VMP, Chaoubah A. One-year comparative evaluation of iStent or iStent inject implantation combined with cataract surgery in a single center. Adv Ther. 2019;36(10):2797–810. https://doi.org/10.1007/s12325-019-01067-5.
Samuelson TW, Sarkisian SR Jr, Lubeck DM, et al. Prospective, randomized, controlled pivotal trial of an ab Interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126(6):811–21. https://doi.org/10.1016/j.ophtha.2019.03.006.
Ferguson T, Swan R, Ibach M, Schweitzer J, Sudhagoni R, Berdahl JP. Evaluation of a trabecular microbypass stent with cataract extraction in severe primary open-angle glaucoma. J Glaucoma. 2018;27(1):71–6. https://doi.org/10.1097/ijg.0000000000000825.
Ferguson TJ, Swan R, Ibach M, Schweitzer J, Sudhagoni R, Berdahl JP. Trabecular microbypass stent implantation with cataract extraction in pseudoexfoliation glaucoma. J Cataract Refract Surg. 2017;43(5):622–6. https://doi.org/10.1016/j.jcrs.2017.02.029.
Hengerer FH, Auffarth GU, Riffel C, Conrad-Hengerer I. Prospective, non-randomized, 36-month study of second-generation trabecular micro-bypass stents with phacoemulsification in eyes with various types of glaucoma. Ophthalmol Therapy. 2018;7(2):405–15. https://doi.org/10.1007/s40123-018-0152-8.
Arriola-Villalobos P, Martinez-de-la-Casa JM, Diaz-Valle D, Morales-Fernandez L, Fernandez-Perez C, Garcia-Feijoo J. Glaukos iStent inject® trabecular micro-bypass implantation associated with cataract surgery in patients with coexisting cataract and open-angle glaucoma or ocular hypertension: a long-term study. J Ophthalmol. 2016;2016:1056573. https://doi.org/10.1155/2016/1056573.
Fea AM, Belda JI, Rękas M, et al. Prospective unmasked randomized evaluation of the iStent inject (®) versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clin Ophthalmol. 2014;8:875–82. https://doi.org/10.2147/opth.s59932.
Voskanyan L, García-Feijoó J, Belda JI, Fea A, Jünemann A, Baudouin C. Prospective, unmasked evaluation of the iStent® inject system for open-angle glaucoma: synergy trial. Adv Ther. 2014;31(2):189–201. https://doi.org/10.1007/s12325-014-0095-y.
Ahmed IIK, Fea A, Au L, et al. A prospective randomized trial comparing Hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma: the COMPARE study. Ophthalmology. 2020;127(1):52–61. https://doi.org/10.1016/j.ophtha.2019.04.034.
Fernández-Barrientos Y, García-Feijoó J, Martínez-de-la-Casa JM, Pablo LE, Fernández-Pérez C, García SJ. Fluorophotometric study of the effect of the Glaukos trabecular microbypass stent on aqueous humor dynamics. Invest Ophthalmol Vis Sci. 2010;51(7):3327–32. https://doi.org/10.1167/iovs.09-3972.
Fea AM. Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma: randomized double-masked clinical trial. J Cataract Refract Surg. 2010;36(3):407.
Patel I, de Klerk TA, Au L. Manchester iStent study: early results from a prospective UK case series. Clin Exp Ophthalmol. 2013;41(7):648–52. https://doi.org/10.1111/ceo.12098.
Spiegel D, García-Feijoó J, García-Sánchez J, Lamielle H. Coexistent primary open-angle glaucoma and cataract: preliminary analysis of treatment by cataract surgery and the iStent trabecular micro-bypass stent. Adv Ther. 2008;25(5):453–64. https://doi.org/10.1007/s12325-008-0062-6.
Seibold LK, Soohoo JR, Ammar DA, Kahook MY. Preclinical investigation of ab interno trabeculectomy using a novel dual-blade device. Am J Ophthalmol. 2013;155(3):524–529.e2. https://doi.org/10.1016/j.ajo.2012.09.023.
Miller VJ, Young CEC, SooHoo JR, et al. Efficacy of Goniotomy with Kahook dual blade in patients with uveitis-associated ocular hypertension. J Glaucoma. 2019;28(8):744–8. https://doi.org/10.1097/ijg.0000000000001298.
Sieck EG, Epstein RS, Kennedy JB, et al. Outcomes of Kahook dual blade Goniotomy with and without phacoemulsification cataract extraction. Ophthalmol Glaucoma. 2018;1(1):75–81. https://doi.org/10.1016/j.ogla.2018.06.006.
Salinas L, Chaudhary A, Berdahl JP, et al. Goniotomy using the Kahook dual blade in severe and refractory glaucoma: 6-month outcomes. J Glaucoma. 2018;27(10):849–55. https://doi.org/10.1097/ijg.0000000000001019.
Dorairaj S, Tam MD. Kahook dual blade excisional Goniotomy and Goniosynechialysis combined with phacoemulsification for angle-closure glaucoma: 6-month results. J Glaucoma. 2019;28(7):643–6. https://doi.org/10.1097/ijg.0000000000001256.
ElMallah MK, Berdahl JP, Williamson BK, et al. Twelve-month outcomes of stand-alone excisional Goniotomy in mild to severe glaucoma. Clin Ophthalmol. 2020;14:1891–7. https://doi.org/10.2147/opth.s256423.
Lee D, King J, Thomsen S, Hirabayashi M, An J. Comparison of surgical outcomes between excisional Goniotomy using the Kahook dual blade and iStent trabecular micro-bypass stent in combination with phacoemulsification. Clin Ophthalmol. 2019;13:2097–102. https://doi.org/10.2147/opth.s224109.
Berdahl JP, Gallardo MJ, ElMallah MK, et al. Six-month outcomes of Goniotomy performed with the Kahook dual blade as a stand-alone glaucoma procedure. Adv Ther. 2018;35(11):2093–102. https://doi.org/10.1007/s12325-018-0803-0.
Shue A, Levine RM, Gallousis GM, Teng CC. Cyclodialysis cleft associated with Kahook dual blade Goniotomy. J Curr Glaucoma Pract. 2019;13(2):74–6. https://doi.org/10.5005/jp-journals-10078-1255.
Ahmed IIK, Rhee DJ, Jones J, et al. Three-year findings of the HORIZON trial: a Schlemm Canal microstent for pressure reduction in primary open-angle glaucoma and cataract. Ophthalmology. 2021;128(6):857–65. https://doi.org/10.1016/j.ophtha.2020.11.004.
Laroche D, Nkrumah G, Ng C. Real-world efficacy of the Hydrus microstent in black and afro-Latinx patients with glaucoma: a retrospective study. Ther Adv Ophthalmol. 2020;12:2515841420964311. https://doi.org/10.1177/2515841420964311.
Pfeiffer N, Garcia-Feijoo J, Martinez-de-la-Casa JM, et al. A randomized trial of a Schlemm's canal microstent with phacoemulsification for reducing intraocular pressure in open-angle glaucoma. Ophthalmology. 2015;122(7):1283–93. https://doi.org/10.1016/j.ophtha.2015.03.031.
Al-Mugheiry TS, Cate H, Clark A, Broadway DC. Microinvasive glaucoma stent (MIGS) surgery with concomitant Phakoemulsification cataract extraction: outcomes and the learning curve. J Glaucoma. 2017;26(7):646–51. https://doi.org/10.1097/ijg.0000000000000691.
Samuelson TW, Chang DF, Marquis R, et al. A Schlemm Canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON study. Ophthalmology. 2019;126(1):29–37. https://doi.org/10.1016/j.ophtha.2018.05.012.
Gandolfi SA, Ungaro N, Ghirardini S, Tardini MG, Mora P. Comparison of surgical outcomes between Canaloplasty and Schlemm's canal scaffold at 24 Months' follow-up. J Ophthalmol. 2016;2016:3410469. https://doi.org/10.1155/2016/3410469.
Jones J, Koch DD, Vold S, et al. Results from the United States cohort of the HORIZON trial of a Schlemm canal microstent to reduce intraocular pressure in primary open-angle glaucoma. J Cataract Refract Surg. 2019;45(9):1305–15. https://doi.org/10.1016/j.jcrs.2019.03.024.
Laspas P, Garcia-Feijoo J, Martinez-de-la-Casa JM, et al. Three-year results of Hydrus microstent with phacoemulsification. Ophthalmol Glaucoma. 2019;2(6):440–2. https://doi.org/10.1016/j.ogla.2019.08.006.
Zebardast N, Zheng C, Jampel HD. Effect of a Schlemm's canal microstent on early Postoperative intraocular pressure after cataract surgery: An analysis of the HORIZON randomized controlled trial. Ophthalmology. 2020;127(10):1303–10. https://doi.org/10.1016/j.ophtha.2020.01.025.
Grover DS, Godfrey DG, Smith O, Feuer WJ. Montes de Oca I, Fellman RL. Gonioscopy-assisted transluminal trabeculotomy, ab interno trabeculotomy: technique report and preliminary results. Ophthalmology. 2014;121(4):855–61. https://doi.org/10.1016/j.ophtha.2013.11.001.
Cubuk MO, Ucgul AY, Unsal E. Gonioscopy-assisted transluminal trabeculotomy as an option after failed trabeculectomy. Int Ophthalmol. 2020;40(8):1923–30. https://doi.org/10.1007/s10792-020-01364-x.
Quan AV, Yannuzzi NA, Chen J, Wang YE, Townsend JH, Chang TC. Gonioscopy-assisted transluminal Trabeculotomy (GATT) in patients with secondary open-angle glaucoma following vitreoretinal surgery. J Glaucoma. 2020;29(4):e23–5. https://doi.org/10.1097/ijg.0000000000001461.
Boese EA, Shah M. Gonioscopy-assisted transluminal Trabeculotomy (GATT) is An effective procedure for steroid-induced glaucoma. J Glaucoma. 2019;28(9):803–7. https://doi.org/10.1097/ijg.0000000000001317.
Salimi A, Nithianandan H, Al Farsi H, Harasymowycz P, Saheb H. Gonioscopy-assisted transluminal Trabeculotomy in younger to middle-aged adults: one-year outcomes. Ophthalmol Glaucoma. 2021;4(2):162–72. https://doi.org/10.1016/j.ogla.2020.08.014.
Hopen ML, Gallardo MJ, Grover D. Gonioscopy-assisted transluminal Trabeculotomy in a pediatric patient with steroid-induced glaucoma. J Glaucoma. 2019;28(10):e156–8. https://doi.org/10.1097/ijg.0000000000001326.
Sachdev A, Khalili A, Choi J, Stead RE, Sung VCT. Gonioscopy-assisted transluminal Trabeculotomy in Uveitic glaucoma secondary to juvenile idiopathic arthritis. J Glaucoma. 2020;29(10):e116–9. https://doi.org/10.1097/ijg.0000000000001641.
Lehmann-Clarke L, Sadeghi Y, Guarnieri A, Sharkawi E. Gonioscopy-assisted transluminal trabeculotomy using an illuminated catheter for infantile primary congenital glaucoma. Case series. Am J Ophthalmol Case Rep. 2020. Published by Elsevier Inc.; 2020;19:100733.
Aktas Z, Ucgul AY, Bektas C, Sahin KS. Surgical outcomes of Prolene Gonioscopy-assisted transluminal Trabeculotomy in patients with moderate to advanced open-angle glaucoma. J Glaucoma. 2019;28(10):884–8. https://doi.org/10.1097/ijg.0000000000001331.
Verner-Cole EA, Ortiz S, Bell NP, Feldman RM. Subretinal suture misdirection during 360 degrees suture trabeculotomy. Am J Ophthalmol. 2006;141(2):391–2. https://doi.org/10.1016/j.ajo.2005.08.038.
Neely DE. False passage: a complication of 360 degrees suture trabeculotomy. J AAPOS. 2005;9(4):396–7. https://doi.org/10.1016/j.jaapos.2005.05.003.
Tracer N, Dickerson JE Jr, Radcliffe NM. Circumferential Viscodilation ab Interno combined with phacoemulsification for treatment of open-angle glaucoma: 12-month outcomes. Clin Ophthalmol. 2020;14:1357–64. https://doi.org/10.2147/opth.s252965.
Vold SD, Williamson BK, Hirsch L, et al. Canaloplasty and Trabeculotomy with the OMNI system in Pseudophakic patients with open-angle glaucoma: the ROMEO study. Ophthalmol Glaucoma. 2021;4(2):173–81. https://doi.org/10.1016/j.ogla.2020.10.001.
Gallardo MJ, Sarkisian SR Jr, Vold SD, et al. Canaloplasty and Trabeculotomy combined with phacoemulsification in open-angle glaucoma: interim results from the GEMINI study. Clin Ophthalmol. 2021;15:481–9. https://doi.org/10.2147/opth.s296740.
Grabska-Liberek I, Duda P, Rogowska M, et al. 12-month interim results of a prospective study of patients with mild to moderate open-angle glaucoma undergoing combined viscodilation of Schlemm's canal and collector channels and 360° trabeculotomy as a standalone procedure or combined with cataract surgery. Eur J Ophthalmol. 2022;32(1):309–15. https://doi.org/10.1177/1120672121998234.
Porsia L, Nicoletti M. Combined viscodilation of Schlemm's canal and collector channels and 360° ab-interno trabeculotomy for congenital glaucoma associated with Sturge-Weber syndrome. Int Med Case Rep J. 2020;13:217–20.
Klabe K, Kaymak H. Standalone Trabeculotomy and Viscodilation of Schlemm's canal and collector channels in open-angle glaucoma using the OMNI surgical system: 24-month outcomes. Clin Ophthalmol. 2021;15:3121–9. https://doi.org/10.2147/opth.s325394.
Hirsch L, Cotliar J, Vold S, et al. Canaloplasty and trabeculotomy ab interno with the OMNI system combined with cataract surgery in open-angle glaucoma: 12-month outcomes from the ROMEO study. J Cataract Refract Surg. 2021;47(7):907–15. https://doi.org/10.1097/j.jcrs.0000000000000552.
Maude Adverse Event Report: Sight Sciences, Inc. Omni Surgical System Pump, Infusion, Ophthalmic. U.S. Food and Drug Administration; 2021. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfmaude/detail.cfm?mdrfoi__id=10399198&pc=MRH.
Reiss G, Clifford B, Vold S, et al. Safety and effectiveness of CyPass Supraciliary micro-stent in primary open-angle glaucoma: 5-year results from the COMPASS XT study. Am J Ophthalmol. 2019;208:219–25. https://doi.org/10.1016/j.ajo.2019.07.015.
Lass JH, Benetz BA, He J, et al. Corneal endothelial cell loss and morphometric changes 5 years after phacoemulsification with or without CyPass micro-stent. Am J Ophthalmol. 2019;208:211–8. https://doi.org/10.1016/j.ajo.2019.07.016.
Junemann A. Twelve-month outcomes following ab interno implantation of suprachoroidal stent and postoperative administration of travoprost to treat open angle glaucoma. 2013.
Meyers J, Katz LJ. Open angle glaucoma treated with a suprachoroidal stent and topical travoprost. 2013.
Postoperative MdlCJ. outcomes through 18 months following implantation of two trabecular micro-bypass stents, one suprachoroidal stent and travoprost in OAG not controlled by trabeculectomy and medications.
Sheybani A, Reitsamer H, Ahmed II. Fluid dynamics of a novel micro-fistula implant for the surgical treatment of glaucoma. Invest Ophthalmol Vis Sci. 2015;56(8):4789–95. https://doi.org/10.1167/iovs.15-16625.
Pérez-Torregrosa VT, Olate-Pérez Á, Cerdà-Ibáñez M, et al. Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Arch Soc Esp Oftalmol. 2016;91(9):415–21. Cirugía combinada mediante facoemulsificación e implante XEN45 con acceso temporal y 2 únicas incisiones. https://doi.org/10.1016/j.oftal.2016.02.006.
Sheybani A, Dick HB, Ahmed II. Early clinical results of a novel ab Interno gel stent for the surgical treatment of open-angle glaucoma. J Glaucoma. 2016;25(7):e691–6. https://doi.org/10.1097/ijg.0000000000000352.
Widder RA, Dietlein TS, Dinslage S, Kühnrich P, Rennings C, Rössler G. The XEN45 gel stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries. Graefes Arch Clin Exp Ophthalmol. 2018;256(4):765–71. https://doi.org/10.1007/s00417-018-3899-7.
Schlenker MB, Gulamhusein H, Conrad-Hengerer I, et al. Efficacy, safety, and risk factors for failure of standalone ab Interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology. 2017;124(11):1579–88. https://doi.org/10.1016/j.ophtha.2017.05.004.
Sng CC, Wang J, Hau S, Htoon HM, Barton K. XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Exp Ophthalmol. 2018;46(4):339–45. https://doi.org/10.1111/ceo.13087.
Yu JTS, Au L. Conjunctival bleb compression as a treatment for hypotony post XEN45 implant in uveitic glaucoma. Eur J Ophthalmol. 2020;30(1):217–20. https://doi.org/10.1177/1120672119836339.
Sheybani A, Lenzhofer M, Hohensinn M, Reitsamer H, Ahmed II. Phacoemulsification combined with a new ab interno gel stent to treat open-angle glaucoma: pilot study. J Cataract Refract Surg. 2015;41(9):1905–9. https://doi.org/10.1016/j.jcrs.2015.01.019.
Reitsamer H, Sng C, Vera V, Lenzhofer M, Barton K, Stalmans I. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019;257(5):983–96. https://doi.org/10.1007/s00417-019-04251-z.
Olgun A, Aktas Z, Ucgul AY. XEN gel implant versus gonioscopy-assisted transluminal trabeculotomy for the treatment of open-angle glaucoma. Int Ophthalmol. 2020;40(5):1085–93. https://doi.org/10.1007/s10792-019-01271-w.
Ucar F, Cetinkaya S. Xen implantation in patients with primary open-angle glaucoma: comparison of two different techniques. Int Ophthalmol. 2020;40(10):2487–94. https://doi.org/10.1007/s10792-020-01427-z.
Lenzhofer M, Kersten-Gomez I, Sheybani A, et al. Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-Centre study. Clin Exp Ophthalmol. 2019;47(5):581–7. https://doi.org/10.1111/ceo.13463.
Ibáñez-Muñoz A, Soto-Biforcos VS, Chacón-González M, et al. One-year follow-up of the XEN® implant with mitomycin-C in pseudoexfoliative glaucoma patients. Eur J Ophthalmol. 2019;29(3):309–14. https://doi.org/10.1177/1120672118795063.
Tan SZ, Walkden A, Au L. One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye (Lond). 2018;32(2):324–32. https://doi.org/10.1038/eye.2017.162.
Grover DS, Flynn WJ, Bashford KP, et al. Performance and safety of a new ab Interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol. 2017;183:25–36. https://doi.org/10.1016/j.ajo.2017.07.023.
Hengerer FH, Kohnen T, Mueller M, Conrad-Hengerer I. Ab Interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma. 2017;26(12):1130–6. https://doi.org/10.1097/ijg.0000000000000803.
Heidinger A, Schwab C, Lindner E, Riedl R, Mossböck G. A retrospective study of 199 Xen45 stent implantations from 2014 to 2016. J Glaucoma. 2019;28(1):75–9. https://doi.org/10.1097/ijg.0000000000001122.
Karimi A, Lindfield D, Turnbull A, et al. A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery. Eye (Lond). 2019;33(3):469–77. https://doi.org/10.1038/s41433-018-0243-8.
Galal A, Bilgic A, Eltanamly R, Osman A. XEN glaucoma implant with Mitomycin C 1-year follow-up: result and complications. J Ophthalmol. 2017;2017:5457246. https://doi.org/10.1155/2017/5457246.
Mansouri K, Guidotti J, Rao HL, et al. Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN gel implant surgery: 1-year results. J Glaucoma. 2018;27(2):140–7. https://doi.org/10.1097/ijg.0000000000000858.
Kirwan JF, Lockwood AJ, Shah P, et al. Trabeculectomy in the 21st century: a multicenter analysis. Ophthalmology. 2013;120(12):2532–9. https://doi.org/10.1016/j.ophtha.2013.07.049.
Pinchuk L, Riss I, Batlle JF, et al. The development of a micro-shunt made from poly (styrene-block-isobutylene-block-styrene) to treat glaucoma. J Biomed Mater Res B Appl Biomater. 2017;105(1):211–21.
Batlle JF, Fantes F, Riss I, et al. Three-year follow-up of a novel aqueous humor microshunt. J Glaucoma. 2016;25(2):e58–65.
Batlle JF, Corona A, Albuquerque R. Long-term results of the PRESERFLO microshunt in patients with primary open-angle glaucoma from a single-center nonrandomized study. J Glaucoma. 2021;30(3):281–6. https://doi.org/10.1097/ijg.0000000000001734.
Baker ND, Barnebey HS, Moster MR, et al. Ab-Externo MicroShunt versus trabeculectomy in primary open-angle glaucoma: one-year results from a 2-year randomized, multicenter study. Ophthalmology. 2021;128:1710. https://doi.org/10.1016/j.ophtha.2021.05.023.
Schlenker MB, Durr GM, Michaelov E, Ahmed IIK. Intermediate outcomes of a novel standalone ab Externo SIBS microshunt with Mitomycin C. Am J Ophthalmol. 2020;215:141–53. https://doi.org/10.1016/j.ajo.2020.02.020.
Scheres LMJ, Kujovic-Aleksov S, Ramdas WD, et al. XEN(®) gel stent compared to PRESERFLO™ MicroShunt implantation for primary open-angle glaucoma: two-year results. Acta Ophthalmol. 2021;99(3):e433–40. https://doi.org/10.1111/aos.14602.
Uram M. Endoscopic cyclophotocoagulation in glaucoma management. Curr Opin Ophthalmol. 1995;6(2):19–29. https://doi.org/10.1097/00055735-199504000-00005.
Pantcheva MB, Kahook MY, Schuman JS, Noecker RJ. Comparison of acute structural and histopathological changes in human autopsy eyes after endoscopic cyclophotocoagulation and trans-scleral cyclophotocoagulation. Br J Ophthalmol. 2007;91(2):248–52. https://doi.org/10.1136/bjo.2006.103580.
Uram M. Ophthalmic laser microendoscope ciliary process ablation in the management of neovascular glaucoma. Ophthalmology. 1992;99(12):1823–8. https://doi.org/10.1016/s0161-6420(92)31718-x.
Chen J, Cohn RA, Lin SC, Cortes AE, Alvarado JA. Endoscopic photocoagulation of the ciliary body for treatment of refractory glaucomas. Am J Ophthalmol. 1997;124(6):787–96. https://doi.org/10.1016/s0002-9394(14)71696-4.
Francis BA, Kawji AS, Vo NT, Dustin L, Chopra V. Endoscopic cyclophotocoagulation (ECP) in the management of uncontrolled glaucoma with prior aqueous tube shunt. J Glaucoma. 2011;20(8):523–7. https://doi.org/10.1097/IJG.0b013e3181f46337.
Lima FE, Magacho L, Carvalho DM, Susanna R Jr, Avila MP. A prospective, comparative study between endoscopic cyclophotocoagulation and the Ahmed drainage implant in refractory glaucoma. J Glaucoma. 2004;13(3):233–7. https://doi.org/10.1097/00061198-200406000-00011.
Wiącek MP, Miszczuk T, Lipiński A, Machalińska A. Safety and efficacy of isolated endoscopic Cyclophotocoagulation in Pseudophakic patients with primary open-angle Glaucoma-12-month follow-up. J Clin Med. 2021;10(18):4212. https://doi.org/10.3390/jcm10184212.
Kahook MY, Lathrop KL, Noecker RJ. One-site versus two-site endoscopic cyclophotocoagulation. J Glaucoma. 2007;16(6):527–30. https://doi.org/10.1097/IJG.0b013e3180575215.
Koduri VA, Reddy AK, Patnaik JL, Palestine AG, Lynch AM, Pantcheva MB. Endoscopic Cyclophotocoagulation combined with phacoemulsification increases risk of persistent anterior uveitis compared to phacoemulsification surgery alone. Clin Ophthalmol. 2021;15:437–43. https://doi.org/10.2147/opth.s294791.
Edmiston AM, SooHoo JR, Seibold LK, Kahook MY, Palestine AG, Pantcheva MB. Postoperative inflammation after endoscopic Cyclophotocoagulation: racial distribution and effect on outcomes. J Glaucoma. 2018;27(3):266–8. https://doi.org/10.1097/ijg.0000000000000884.
Beardsley R, Law SK, Caprioli J, et al. Comparison of Outcomes between Endoscopic and Transcleral Cyclophotocoagulation. Vision (Basel). 2017;1(4):24. https://doi.org/10.3390/vision1040024.
Clement CI, Kampougeris G, Ahmed F, Cordeiro MF, Bloom PA. Combining phacoemulsification with endoscopic cyclophotocoagulation to manage cataract and glaucoma. Clin Exp Ophthalmol. 2013;41(6):546–51. https://doi.org/10.1111/ceo.12051.
Lindfield D, Ritchie RW, Griffiths MF. 'Phaco-ECP': combined endoscopic cyclophotocoagulation and cataract surgery to augment medical control of glaucoma. BMJ Open. 2012;2(3)doi:10.1136/bmjopen-2011-000578:e000578.
Fea AM, Cattel F, Gandolfi S, Buseghin G, Furneri G, Costagliola C. Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle glaucoma in Italy. BMC Health Serv Res. 2021;21(1):824. https://doi.org/10.1186/s12913-021-06862-x.
Bartelt-Hofer J, Flessa S. Comparative efficacy and cost-utility of combined cataract and minimally invasive glaucoma surgery in primary open-angle glaucoma. Int Ophthalmol. 2020;40(6):1469–79. https://doi.org/10.1007/s10792-020-01314-7.
Ngan K, Fraser E, Buller S, Buller A. A cost minimisation analysis comparing iStent accompanying cataract surgery and selective laser trabeculoplasty versus topical glaucoma medications in a public healthcare setting in New Zealand. Graefes Arch Clin Exp Ophthalmol. 2018;256(11):2181–9. https://doi.org/10.1007/s00417-018-4104-8.
Ordóñez JE, Ordóñez A, Osorio UM. Cost-effectiveness analysis of iStent trabecular micro-bypass stent for patients with open-angle glaucoma in Colombia. Curr Med Res Opin. 2019;35(2):329–40. https://doi.org/10.1080/03007995.2018.1506022.
Le HG, Ehrlich JR, Venkatesh R, et al. A sustainable model for delivering high-quality, efficient cataract surgery in Southern India. Health Aff (Millwood). 2016;35(10):1783–90. https://doi.org/10.1377/hlthaff.2016.0562.
Cui QN, Hays RD, Tarver ME, et al. Vision-targeted health-related quality-of-life survey for evaluating minimally invasive glaucoma surgery. Am J Ophthalmol. 2021;229:145–51. https://doi.org/10.1016/j.ajo.2021.03.064.
Pahlitzsch M, Klamann MK, Pahlitzsch ML, Gonnermann J, Torun N, Bertelmann E. Is there a change in the quality of life comparing the micro-invasive glaucoma surgery (MIGS) and the filtration technique trabeculectomy in glaucoma patients? Graefes Arch Clin Exp Ophthalmol. 2017;255(2):351–7. https://doi.org/10.1007/s00417-016-3550-4.
Al Habash A, Nagshbandi AA. Quality of life after combined cataract and minimally invasive glaucoma surgery in glaucoma patients. Clin Ophthalmol. 2020;14:3049–56. https://doi.org/10.2147/opth.s276124.
Alasbali T, Smith M, Geffen N, et al. Discrepancy between results and abstract conclusions in industry- vs nonindustry-funded studies comparing topical prostaglandins. Am J Ophthalmol. 2009;147(1):33–38.e2. https://doi.org/10.1016/j.ajo.2008.07.005.
Wise A, Mannem D, Anderson JM, Weaver M, Hartwell M, Vassar M. Do author conflicts of interest and industry sponsorship influence outcomes of systematic reviews and meta-analyses regarding glaucoma interventions? a cross-sectional analysis. J Glaucoma. 2021;30(4):293–9. https://doi.org/10.1097/ijg.0000000000001798.
Miller ME, Siegler M, Angelos P. Ethical issues in surgical innovation. World J Surg. 2014;38(7):1638–43. https://doi.org/10.1007/s00268-014-2568-1.
Johnson J, Rogers W. Innovative surgery: the ethical challenges. J Med Ethics. 2012;38(1):9–12. https://doi.org/10.1136/jme.2010.042150.
Myers JS, Masood I, Hornbeak DM, et al. Prospective evaluation of two iStent(®) trabecular stents, one iStent supra(®) Suprachoroidal stent, and Postoperative prostaglandin in refractory glaucoma: 4-year outcomes. Adv Ther. 2018;35(3):395–407. https://doi.org/10.1007/s12325-018-0666-4.
Liesegang TJ, Bartley GB. Toward transparency of financial disclosure. Ophthalmology. 2014;121(11):2077–8. https://doi.org/10.1016/j.ophtha.2014.08.039.
Campbell EG, Weissman JS, Ehringhaus S, et al. Institutional academic industry relationships. JAMA. 2007;298(15):1779–86. https://doi.org/10.1001/jama.298.15.1779.
Anderson TS, Good CB, Gellad WF. Prevalence and compensation of academic leaders, professors, and trustees on publicly traded US healthcare company boards of directors: cross sectional study. BMJ. 2015;351:h4826. https://doi.org/10.1136/bmj.h4826.
Shaarawy TM, Grehn F. Guidelines on design and reporting of glaucoma surgical trials. Kugler Publications; 2009.
Mathew DJ, McKay BR, Basilious A, Belkin A, Trope GE, Buys YM. Adherence to world glaucoma association guidelines for surgical trials in the era of microinvasive glaucoma surgeries. Ophthalmol Glaucoma. 2019;2(2):78–85. https://doi.org/10.1016/j.ogla.2019.01.007.
Mansberger SL, Gordon MO, Jampel H, et al. Reduction in intraocular pressure after cataract extraction: the ocular hypertension treatment study. Ophthalmology. 2012;119(9):1826–31. https://doi.org/10.1016/j.ophtha.2012.02.050.
Wang SY, Azad AD, Lin SC, Hernandez-Boussard T, Pershing S. Intraocular pressure changes after cataract surgery in patients with and without glaucoma: An informatics-based approach. Ophthalmol Glaucoma. 2020;3(5):343–9. https://doi.org/10.1016/j.ogla.2020.06.002.
Leal I, Chu CJ, Yang YY, Manasses DM, Sebastian RT, Sparrow JM. Intraocular pressure reduction after real-world cataract surgery. J Glaucoma. 2020;29(8):689–93. https://doi.org/10.1097/ijg.0000000000001527.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wu, A.M., Ondeck, C.L., Zebardast, N. (2023). Microinvasive Glaucoma Surgery. In: Tsui, E., Fung, S.S.M., Singh, R.B. (eds) Current Advances in Ocular Surgery. Current Practices in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-99-1661-0_15
Download citation
DOI: https://doi.org/10.1007/978-981-99-1661-0_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-1660-3
Online ISBN: 978-981-99-1661-0
eBook Packages: MedicineMedicine (R0)